Krystal Biotech (KRYS) Interest Expenses (2021)

Krystal Biotech's (KRYS) quarterly Interest Expenses came in at $1.5 million in Q1 2021.

Krystal Biotech (KRYS) Interest Expenses (2021) Analysis & Trends

Krystal Biotech has disclosed Interest Expenses across 1 years of filings, most recently posting $1.5 million for Q1 2021.

Interest Expenses for Q1 2021 came in at $1.5 million, changed N/A year-over-year; the trailing twelve-month figure through Dec 2021 was $1.5 million (changed N/A YoY), and the FY2021 annual result was $1.5 million, changed N/A from the prior year.
Interest Expenses came in at $1.5 million for Q1 2021 at Krystal Biotech.
In the past five years, Interest Expenses ranged from a high of $1.5 million in Q1 2021 to a low of $1.5 million in Q1 2021.

Peer Comparison

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Int Expense (Qtr)
1	Alterity Therapeutics	925,601.88 Bn	925,601.85 Bn	-	-
2	Belite Bio	58,560.00 Bn	58,560.00 Bn	-	-
3	Quantum Biopharma	17,284.41 Bn	17,284.40 Bn	-	-
4	Legend Biotech	2,809.00 Bn	2,808.71 Bn	242.10 Mn	-5.50 Mn
5	Evaxion A	1,334.43 Bn	1,334.42 Bn	-	-332,000.00
6	Akari Therapeutics	1,312.27 Bn	1,312.26 Bn	-	61,000.00
7	Psyence Biomedical	212.16 Bn	212.16 Bn	-	-2,753.00
8	Vertex Pharmaceuticals	114.83 Bn	107.58 Bn	2.59 Bn	-
9	Abivax	91.96 Bn	91.96 Bn	-	-5.58 Mn
10	Krystal Biotech	10.23 Bn	9.41 Bn	110.03 Mn	-

Historic Data

Download Data

Date	Value
Mar 31, 2021	1.49 Mn
Mar 31, 2021	1.49 Mn